Intrinsiqq
Medifast Inc. logo

Medifast Inc. (MED) Insider Trading

Last 12 months

Insiders bought $1.67M and sold $226k on the open market.

All of the selling was scheduled in advance under 10b5-1 plans.

Net open-market
+$1.44M
5 buys · 1 sale
Under a 10b5-1 plan
100%
of the value sold
Insiders who bought / sold
3 / 1
executives and directors
Last open-market buy
Aug 2026
Aug 26, 2026

Get an email when MED's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 28 – 2910b5-1 plan
    Daniel R Chard
    Director · sold 19,089 at avg $11.86
    $226k
    5.4% of stake
  • Aug 26
    Parsa Kiai
    Director · bought 43,150 at avg $12.26
    $529k
    New position
  • Aug 24
    Parsa Kiai
    Director · bought 4,329 at avg $12.00
    $52k
    29% of stake
  • Aug 19 – 20
    Parsa Kiai
    Director · bought 72,487 at avg $11.62
    $843k
    New position
  • May 8 – 11
    Scott Schlackman
    Director · bought 5,000 at avg $12.59
    $63k
    20% of stake
  • Mar 20
    Daniel R Chard
    Chairman & CEO · bought 17,678 at $10.11
    $179k
    5.2% of stake
  • Jun 13, 2025
    Daniel R Chard
    Chairman & CEO · bought 381 at $13.13
    $5k
    0.1% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MED, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Miscellaneous Food Preparations & Kindred Products

Spot a number that looks wrong? Check it in MED's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MED

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.